Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PCRX · against 457 other Healthcare companies of similar size
Ranked #167 of 458 · scores higher than 64% of peers · safety percentile 66
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)52 peers with a safety percentile of 60–69, including PCRX · Click a bar to see the companies
A mix: stronger current ratio and beta, but weaker debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 435 reported | 0.61× | 0.21× | 26% | 33% | |
| BetaLower is better · 430 reported | 0.25 | 0.52 | 71% | 33% | |
| Current ratioHigher is better · 445 reported | 5.04× | 2.82× | 74% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 1.0B USD | 99 | 35 | |
| 163 | 14.2B HKD (≈$1.8B) | 67 | 64 | |
| 164 | 15.8B HKD (≈$2.0B) | 67 | 61 | |
| 165 | 9.3B CNY (≈$1.3B) | 67 | 56 | |
| 166 | 13.5B CNY (≈$1.9B) | 66 | 67 | |
| 167 | 1.5B USD | 66 | 59 | |
| 168 | 9.2B CNY (≈$1.3B) | 66 | 53 | |
| 169 | 10.2B CNY (≈$1.4B) | 66 | 69 | |
| 170 | 1.3B USD | 65 | 30 | |
| 171 | 18.8B CNY (≈$2.6B) | 65 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score